1. Home
  2. LGIH vs QURE Comparison

LGIH vs QURE Comparison

Compare LGIH & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$40.56

Market Cap

1.1B

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$26.74

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
QURE
Founded
2003
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
LGIH
QURE
Price
$40.56
$26.74
Analyst Decision
Hold
Buy
Analyst Count
5
14
Target Price
$75.90
$45.00
AVG Volume (30 Days)
415.7K
2.0M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.67
EPS
0.09
N/A
Revenue
$1,705,504,000.00
$13,107,000.00
Revenue This Year
$2.32
$126.12
Revenue Next Year
$17.94
$200.43
P/E Ratio
$487.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.55
$8.73
52 Week High
$69.42
$71.50

Technical Indicators

Market Signals
Indicator
LGIH
QURE
Relative Strength Index (RSI) 39.15 67.45
Support Level $34.71 $21.16
Resistance Level $41.50 $28.63
Average True Range (ATR) 2.33 2.27
MACD -0.64 0.72
Stochastic Oscillator 1.03 76.65

Price Performance

Historical Comparison
LGIH
QURE

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: